Stephens upgraded Evolent Health (EVH) to Overweight from Equal Weight with an unchanged price target of $7.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVH:
- BMO Capital’s Optimistic Buy Rating for Evolent Health Driven by Strategic Stabilization and Growth Initiatives
- Evolent Health initiated with an Outperform at BMO Capital
- Evolent Health price target lowered to $12 from $18 at Oppenheimer
- Evolent Health price target lowered to $11 from $13 at Citizens JMP
- Evolent Health Inc. Reports Strong Q3 Earnings and Strategic Growth